4/A//SEC Filing
Essex Woodlands Fund IX-GP, L.P. 4/A
Accession 0000899243-23-018661
CIK 0001314102other
Filed
Sep 5, 8:00 PM ET
Accepted
Sep 6, 7:10 PM ET
Size
12.9 KB
Accession
0000899243-23-018661
Insider Transaction Report
Form 4/AAmended
Essex Woodlands Fund IX, L.P.
10% Owner
Transactions
- Sale
Common Stock, $0.001 par value
2023-09-01$9.90/sh−20,000$197,982→ 3,490,921 total(indirect: See Footnotes)
EW Healthcare Partners-A, L.P.
10% Owner
Transactions
- Sale
Common Stock, $0.001 par value
2023-09-01$9.90/sh−20,000$197,982→ 3,490,921 total(indirect: See Footnotes)
Essex Woodlands IX, LLC
10% Owner
Transactions
- Sale
Common Stock, $0.001 par value
2023-09-01$9.90/sh−20,000$197,982→ 3,490,921 total(indirect: See Footnotes)
Essex Woodlands Fund IX-GP, L.P.
10% Owner
Transactions
- Sale
Common Stock, $0.001 par value
2023-09-01$9.90/sh−20,000$197,982→ 3,490,921 total(indirect: See Footnotes)
Footnotes (3)
- [F1]The share total shown above is the aggregate amount of shares of Common Stock sold by EW Healthcare Partners, L.P. ("EWHP") and EW Healthcare Partners-A, L.P. ("EWHP-A") on the date set forth above. EWHP sold 19,226 shares of the amount shown above, and EWHP-A sold 774 shares of the amount shown above. EWHP now holds a total of 3,355,921 shares of Common Stock of the Issuer and EWHP-A now holds a total of 135,000 shares of Common Stock of the Issuer.
- [F2]Price is the volume weighted average selling price of all sales by the Reporting Persons on the transaction date within a one dollar range. Actual prices ranged from $9.73 to $10.11. The Reporting Persons hereby undertake to provide upon request of the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F3]Essex Woodlands Fund IX-GP, L.P. (the "EW Fund IX GP"), is the general partner of each of EW Healthcare Partners, L.P. ("EWHP") and EW Healthcare Partners-A, L.P. ("EWHP-A" and together with EWHP, the "EWHP Funds"). Essex Woodlands IX, LLC (the "General Partner") is the general partner of EW Fund IX GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EWHP Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Scott Barry, Ron Eastman, Petri Vainio and Steve Wiggins (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Fund IX GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.
Documents
Issuer
EyePoint Pharmaceuticals, Inc.
CIK 0001314102
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001652285
Filing Metadata
- Form type
- 4/A
- Filed
- Sep 5, 8:00 PM ET
- Accepted
- Sep 6, 7:10 PM ET
- Size
- 12.9 KB